Methodology

All entries for: Nanjing Reju Therapeutics Co., Ltd.

January 15, 2026

Nanjing Reju Therapeutics Co., Ltd.

Orphan Drug Designation

treatment of idiopathic pulmonary fibrosis

Disease Area: Rare Diseases
Source
Source
Scroll to Top